When was your last pin of peps, prior to bloods
Clinical and experimental endpoints Across experimental modelsparticularly in AKIH therapy consistently improves oxidative stress markers (for example, malondialdehyde, glutathione, superoxide dismutase), inflammatory cytokine levels, and histological injury scores.8,13,24,34,40,56 Interest also exists in H ability to mitigate cisplatin-induced nephrotoxicity without reducing antitumor efficacy.21,37,57 Early clinical work, including small-scale dialysis studies, reports lowered fatigue and inflammation but insufficient data on long-term outcomes such as survival or progression to end-stage renal disease.7,30,43,44,46,47 While these findings strongly suggest multifaceted renoprotectionencompassing antioxidant, anti-inflammatory, and antifibrotic effectsfurther research is needed to refine clinical endpoints and confirm the full scope of H therapeutic value
doi: 10.1016/j.clinthera.2019.02.011 489 Carlo-StellaNBozziniSDe SilvestriASbarsiIPizzocheroCLorussoLet al
Human studies support these findings: A randomized controlled trial demonstrated that a six-month zinc supplementation regimen in older adults increased plasma zinc levels and decreased markers of inflammation, including high-sensitivity C-reactive protein, IL-6, MCP-1, and VCAM-1
